Restructuring and Other Charges, Net (Tables)

9 Months Ended

Sep. 30, 2023

Restructuring and Related Activities [Abstract]

Changes in Employee-Related Restructuring Liabilities

Changes in Restructuring Liabilities

Changes in restructuring liabilities during the nine months ended September 30, 2023 were as follows:

(DOLLARS IN MILLIONS)	Balance at December 31, 2022		Additional Charges (Reversals), Net		Non-Cash Charges		Cash Payments		Balance at September 30, 2023
Frutarom Integration Initiative
Severance	$	4	$	(3)	$	—	$	(1)	$	—
Other Restructuring Charges
Severance	1		(1)		—		—		—
N&B Merger Restructuring Liability
Severance	9		—		—		(8)		1
Other	1		2		(2)		(1)		—
2023 Restructuring Program
Severance	—		63		—		(39)		24
Total Restructuring and other charges	$	15	$	61	$	(2)	$	(49)	$	25

Restructuring liabilities are presented in “Other current liabilities” on the Consolidated Balance Sheets.

Charges by Segment

The following table summarizes the total amount of costs incurred in connection with these restructuring programs and activities by segment:

	Three Months Ended September 30,				Nine Months Ended September 30,
(DOLLARS IN MILLIONS)	2023		2022		2023		2022
Nourish	$	1	$	—	$	33	$	3
Health & Biosciences	1		1		12		2
Scent	—		(5)		14		—
Pharma Solutions	—		—		2		—
Total Restructuring and other charges	$	2	$	(4)	$	61	$	5